Compare HAE & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HAE | ICHR |
|---|---|---|
| Founded | 1971 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.0B |
| IPO Year | 1996 | 2016 |
| Metric | HAE | ICHR |
|---|---|---|
| Price | $105.01 | $65.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 6 |
| Target Price | ★ $84.13 | $49.50 |
| AVG Volume (30 Days) | 713.3K | ★ 915.0K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | $910,373,000.00 | ★ $947,652,000.00 |
| Revenue This Year | N/A | $20.51 |
| Revenue Next Year | $5.23 | $17.08 |
| P/E Ratio | $125.38 | ★ N/A |
| Revenue Growth | N/A | ★ 11.61 |
| 52 Week Low | $47.32 | $14.06 |
| 52 Week High | $92.25 | $113.58 |
| Indicator | HAE | ICHR |
|---|---|---|
| Relative Strength Index (RSI) | 83.12 | 40.25 |
| Support Level | $79.52 | $61.20 |
| Resistance Level | N/A | $75.84 |
| Average True Range (ATR) | 3.10 | 5.33 |
| MACD | 1.15 | 0.08 |
| Stochastic Oscillator | 93.64 | 8.24 |
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.